Clinical trial
Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients
NCT00128908 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other · Terminated
Key facts
| NCT number | NCT00128908 |
|---|---|
| Title | Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients |
| Official title | Sequential HAART in Treatment Resistant HIV-1 Infected Patients |
| Lead sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Other |
| Collaborators | Dutch AIDS Fund |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Standard Continuous Highly Active Antiretroviral Therapy (HAART), Rapidly Cycled HAART |
| Enrollment | 3 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Aug 10, 2005 |
| Last update posted | Sep 15, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: